The DOI matches its Crossref record; 42 of the 45 references it cites were found in a registry or an index.
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
Abstract
apoE-deficient mice have been created by homologous recombination in ES cells. On a low fat, low cholesterol chow diet these animals have plasma cholesterol levels of 494 mg/dl compared with 60 mg/dl in control animals, and when challenged with a high fat Western-type diet, these animals have plasma cholesterol levels of 1821 mg/dl compared with 132 mg/dl in controls. This marked hypercholesterolemia is primarily due to elevated levels of very low and intermediate density lipoproteins. At 10 weeks of age, apoE-deficient mice have already developed atherosclerotic lesions in the aorta and coronary and pulmonary arteries. apoE-deficient mice are a promising small animal model to help understand the role of apoE in vivo and the genetic and environmental determinants of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increased amounts of apoA-IV in VLDL and IDL we observed were seen in other reports of apoE deficiency4,5,9 and in apoE-deficient mice.31”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [31]
In the citing paper
“Increased amounts of apoA-I were observed in LDL from an apoE-deficient patient9 and in VLDL from ApoE knockout mice.31”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [31]
In the citing paper
“Disorders of apoE are associated with atherosclerosis, which causes dyslipidemia and myocardial infarction, and apoE-deficient mice are used as model animals for atherosclerosis2, 3).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [3]
In the citing paper
“Disorders of apoE are associated with atherosclerosis, which causes dyslipidemia and myocardial infarction, and apoE-deficient mice are used as model animals for atherosclerosis2, 3).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [3]
In the citing paper
“In vivo and in vitro studies have shown that mutations in apoE that diminish binding of apoE-containing lipoproteins to the LDL receptor are associated with high plasma cholesterol levels and cause premature atherosclerosis in humans and experimental animals ( 1-3, 7, 8 ).”
From Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4 (2011) · cites this paper as [1]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 16,688
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,990
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,045
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., & Clift, S. (1991) · Nature · doi:10.1038/353265a0 · Cited by 985
Self-citation
Cited by
Sorted by citations
Items 801–900 of 1,010
Tsukamoto, K., Tangirala, R. K., Chun, S. H., Usher, D. C., Puré, E., & Rader, D. J. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0028 · Cited by 56
Bowen‐Pope, D. F., & Raines, E. W. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.179556 · Cited by 61
Jiang, Y., Du, H., Liu, X., Fu, X., Li, X., & Cao, Q. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1616296 · Cited by 56
Wang, J., Gagné, S. M., Sykes, B. D., & Ryan, R. O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17912 · Cited by 56
Zhang, X., Urbieta-Caceres, V. H., Eirin, A., Bell, C. C., Crane, J. A., Tang, H., Jordan, K. L., Oh, Y.-K., Zhu, X.-Y., Korsmo, M. J., et al. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.07.010 · Cited by 55
Tsukamoto, K., Mani, D. R., Shi, J., Zhang, S., Haagensen, D. E., Otsuka, F., Guan, J., Smith, J. D., Weng, W., Liao, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315986110 · Cited by 55
Self-citationPPARα and PPARγ activators suppress the monocyte-macrophage apoB-48 receptor
Haraguchi, G., Kobayashi, Y., Brown, M. L., Tanaka, A., Isobe, M., Gianturco, S. H., & Bradley, W. A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300077-jlr200 · Cited by 57
Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
Fang, B., Ren, X., Wang, Y., Li, Z., Zhao, L., Zhang, M., Chu, L., Zhang, Z., Chen, L., Li, X., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.036632 · Cited by 55
Diabetic nephropathy: Of mice and men
Breyer, M. D., Böttinger, E. P., Brosius, F. C., Coffman, T. M., Fogo, A. B., Harris, R. C., Heilig, C. W., & Sharma, K. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.004 · Cited by 55
Narvekar, P., Díaz, M. B., Krones, A., Hardeland, U., Strzoda, D., Stöhr, S., Frohme, M., & Herzig, S. (2009) · Diabetes · doi:10.2337/db08-1184 · Cited by 61
Absence of central cholinergic deficits in ApoE knockout mice
Anderson, R., & Higgins, G. A. (1997) · Psychopharmacology · doi:10.1007/s002130050329 · Cited by 55
ApoE Induces Serum Paraoxonase PON1 Activity and Stability Similar to ApoA-I
Gaidukov, L., I, V. R., Yacobson, S., Rosenblat, M., Aviram, M., & Tawfik, D. S. (2009) · Biochemistry · doi:10.1021/bi9013227 · Cited by 54
RAGE and its ligands: a lasting memory in diabetic complications?
Yan, S.-F., Ramasamy, R., Bucciarelli, L. G., Wendt, T., Lee, L. K., Hudson, B. I., Stenr, D. M., Lalla, E., Yan, S. D., Rong, L., et al. (2004) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2004.001 · Cited by 53
Kitajima, K., Marchadier, D. H. L., Miller, G. C., Gao, G.-P., Wilson, J. M., & Rader, D. J. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000231520.26490.54 · Cited by 54
A wild-type mouse-based model for the regression of inflammation in atherosclerosis
Peled, M., Nishi, H., Weinstock, A., Barrett, T. J., Zhou, F. Y., Quezada, A., & Fisher, E. A. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173975 · Cited by 54
Hayek, T., Hussein, K., Aviram, M., COLEMAN, R., Keidar, S., PAVOLTZKY, E., & KAPLAN, M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.018 · Cited by 54
Self-citationMadan, M., Bishayi, B., Hoge, M., Messas, E., & Amar, S. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.026 · Cited by 54
n‐3 fatty acids: Antiatherosclerotic effects
Caterina, R. D., & Zampolli, A. (2001) · Lipids · doi:10.1007/s11745-001-0685-9 · Cited by 54
Dietary Cholesterol Plays a Role in CD36-Mediated Atherogenesis in LDLR-Knockout Mice
Kennedy, D. J., Kuchibhotla, S., Guy, E. C., Park, Y. M., Nimako, G. K., Vanegas, D., Morton, R. E., & Febbraio, M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191940 · Cited by 60
Pejnovic, N. N., Vratimos, A., Lee, S. E., Popadic, D. M., Takeda, K., Akira, S., & Chan, W. L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.032 · Cited by 53
Aprahamian, T. R., Zhong, X., Amir, S., Binder, C. J., Chiang, L.-K., Al‐Riyami, L., Gharakhanian, R., Harnett, M. M., Harnett, W., & Rifkin, I. R. (2015) · International Journal for Parasitology · doi:10.1016/j.ijpara.2014.12.006 · Cited by 53
Tahara, S., Morooka, T., Wang, Z., Bezerra, H. G., Rollins, A. M., Simon, D. I., & Costa, M. A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.243626 · Cited by 53
Sphingolipids in obesity and related complications
Li, P.-L. (2016) · Frontiers in bioscience · doi:10.2741/4474 · Cited by 55
Models of retinal diseases and their applicability in drug discovery
Malek, G., Busik, J. V., Grant, M. B., & Choudhary, M. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1430136 · Cited by 53
Inamura, N., Araki, T., Enokido, Y., Nishio, C., Aizawa, S., & Hatanaka, H. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000515)60:4 · Cited by 33
Major, A. S., Dove, D. E., Ishiguro, H., Su, Y. R., Brown, A. M., Liu, L., Carter, K. J., Linton, M. F., & Fazio, S. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1101.097798 · Cited by 53
Kawakami, A., Tanaka, A., Chiba, T., Nakajima, K., Shimokado, K., & Yoshida, M. (2003) · Circulation · doi:10.1161/01.cir.0000093278.75565.87 · Cited by 53
Chang, X., Yan, H., Xu, Q., Xia, M., Bian, H., Zhu, T., & Gao, X. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-86 · Cited by 52
Apolipoprotein E2 Transgenic Rabbits
Huang, Y., Schwendner, S. W., Rall, S. C., Sanan, D. A., & Mahley, R. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22685 · Cited by 52
NOS inhibition accelerates atherogenesis: reversal by exercise
Niebauer, J., Maxwell, A. J., Lin, P. S., Wang, D., Tsao, P. S., & Cooke, J. P. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00360.2001 · Cited by 53
Jiang, F., Guo, Y., Salvemini, D., & Dusting, G. J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705354 · Cited by 51
Lupu, F., Heim, D. A., Bachmann, F., & Kruithof, E. K. O. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.9.1438 · Cited by 52
Chapter 2 The Potential Role of Heat Shock Proteins in Cardiovascular Disease
Ghayour‐Mobarhan, M., Rahsepar, A. A., Tavallaie, S., Rahsepar, S., & Ferns, G. A. (2009) · Advances in clinical chemistry · doi:10.1016/s0065-2423(09)48002-8 · Cited by 50
McNeill, E., Channon, K. M., & Greaves, D. R. (2010) · Clinical Science · doi:10.1042/cs20090488 · Cited by 51
Doddapattar, P., Radović, B., Patankar, J. V., Obrowsky, S., Jandl, K., Nusshold, C., Kolb, D., Vujić, N., Doshi, L. S., Chandak, P. G., et al. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200794 · Cited by 51
Linton, M. F., & Fazio, S. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00003 · Cited by 51
Wang, S. S., Shi, W., Wang, X., Velky, L., Greenlee, S., Wang, M. T., Drake, T. A., & Lusis, A. J. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.148106 · Cited by 51
Reduced Paraoxonase 1 Activity as a Marker for Severe Coronary Artery Disease
Zhou, C., Cao, J., Shang, L., Tong, C., Hu, H., Wang, H., Fan, D., & Yu, H. (2013) · Disease Markers · doi:10.1155/2013/816189 · Cited by 52
Adenosine receptors: Modulators of lipid availability that are controlled by lipid levels
Leiva, A., Guzmán‐Gutiérrez, E., Contreras‐Duarte, S., Fuenzalida, B., Cantin, C., Carvajal, L., Salsoso, R., Gutiérrez, J., Pardo, F., & Sobrevía, L. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.007 · Cited by 51
Quantification of Atherosclerosis in Mice
Centa, M., Ketelhuth, D. F. J., Malin, S., & Gisterå, A. (2019) · Journal of Visualized Experiments · doi:10.3791/59828 · Cited by 55
A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome
Kiaie, N., Gorabi, A. M., Penson, P. E., Watts, G. F., Johnston, T. P., Banach, M., & Sahebkar, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.005 · Cited by 51
Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis
Goldschmidt‐Clermont, P. J. (2003) · American Heart Journal · doi:10.1016/j.ahj.2003.09.002 · Cited by 51
Khallou‐Laschet, J., Caligiuri, G., Tupin, E., Gaston, A., Poirier, B., Groyer, É., Urbain, D., Maisnier‐Patin, S., Sarkar, R., Kaveri, S. V., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000171995.22284.9a · Cited by 51
Rubinsztein, D. C. (1995) · Psychological Medicine · doi:10.1017/s0033291700036138 · Cited by 51
van Vlijmen, B. J. M., van Dijk, K. W., Hof, H. B. V., van Gorp, P. J., van der Zee, A., van der Boom, H., Breuer, M. L., Hofker, M. H., & Havekes, L. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30595 · Cited by 52
Shih, D. M., Shaposhnik, Z., Meng, Y., Rosales, M., Wang, X., Wu, J., Ratiner, B., Zadini, F., Zadini, G., & Lusis, A. J. (2013) · The FASEB Journal · doi:10.1096/fj.12-223008 · Cited by 52
Zhu, Y. S., Li, T., Din, A. U., Hassan, A., Wang, Y., & Wang, G. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09681-7 · Cited by 50
Knockout rat models mimicking human atherosclerosis created by Cpf1-mediated gene targeting
Lee, J. G., Ha, C. H., Yoon, B., Cheong, S.-A., Kim, G., Lee, D. J., Woo, D., Kim, Y., Nam, S.-Y., Lee, S.-W., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38732-2 · Cited by 50
Basu, D., & Bornfeldt, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00504 · Cited by 51
T-lymphocytes and monocytes in atherogenesis
Schmitz, G., Herr, A. S., & Rothe, G. (1998) · Herz · doi:10.1007/bf03044602 · Cited by 50
Morphometry and strain distribution of the C57BL/6 mouse aorta
Guo, X., Kono, Y., Mattrey, R. F., & Kassab, G. S. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00224.2002 · Cited by 50
Nicoletti, A., Paulsson, G. B., Caligiuri, G., Zhou, X., & Hansson, G. K. (2000) · Molecular Medicine · doi:10.1007/bf03401937 · Cited by 50
Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury
Lomnitski, L., Chapman, S., Hochman, A., Kohen, R., Shohami, E., Chen, Y., Trembovler, V., & Michaelson, D. M. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00010-1 · Cited by 51
Cholesterol and Coronary Heart Disease
Grundy, S. M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440320055006 · Cited by 50
Legumes as Functional Food for Cardiovascular Disease
Angeles, J. G. C., Villanueva, J. C., Uy, L. Y., Mercado, S. M. Q., Tsuchiya, M. C., Lado, J. P., Angelia, M. R. N., Bercansil, M. C. M. L., Estacio, M. A. C., & Torio, M. A. O. (2021) · Applied Sciences · doi:10.3390/app11125475 · Cited by 51
Matsushima, Y., Sekine, T., Kondo, Y., Sakurai, T., Kameo, K., Tachibana, M., & Murakami, S. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03828.x · Cited by 49
Arruda, R. M. P., Peotta, V. A., Meyrelles, S. S., & Vasquez, E. C. (2005) · Hypertension · doi:10.1161/01.hyp.0000182154.61862.52 · Cited by 49
Zebrafish Models for Dyslipidemia and Atherosclerosis Research
Schlegel, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00159 · Cited by 54
Fancher, I. S., Ahn, S. J., Adamos, C., Osborn, C. V., Oh, M., Fang, Y. H., Reardon, C. A., Getz, G. S., Phillips, S. A., & Levitan, I. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007430 · Cited by 47
Datta, G., Garber, D. W., Chung, B. H., Chaddha, M., Dashti, N., Bradley, W. A., Gianturco, S. H., & Anantharamaiah, G. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31620-5 · Cited by 49
Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow
Eck, M. V., Herijgers, N., Vidgeon-Hart, M., Pearce, N. J., Hoogerbrugge, P. M., Groot, P. H. E., & van Berkel, T. J. C. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00372-x · Cited by 49
Reis, E. D., Roqué, M., Dansky, H. M., Fallon, J. T., Badimón, J. J., Cordon‐Cardo, C., Shiff, S. J., & Fisher, E. A. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210394497 · Cited by 49
Structural and metabolic consequences of liposome–lipoprotein interactions
Rodrigueza, W. V., Phillips, M. C., & Williams, K. J. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00130-0 · Cited by 49
Sirker, A. A., Astroulakis, Z., & Hill, J. M. (2009) · Clinical Science · doi:10.1042/cs20080001 · Cited by 49
Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor
Dyer, C. A., Cistola, D. P., Parry, G. C., & Curtiss, L. K. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39756-x · Cited by 49
Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems
Lijnen, H. R. (2000) · Fibrinolysis and Proteolysis · doi:10.1054/fipr.2000.0065 · Cited by 49
Genis, I., Fisher, A., & Michaelson, D. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720206.x · Cited by 49
Retention of Oxidized LDL by Extracellular Matrix Proteoglycans Leads to Its Uptake by Macrophages
Kaplan, M., & Aviram, M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.386 · Cited by 49
Lamping, K. G., Nuno, D. W., Chappell, D. A., & Faraci, F. M. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.4.r1023 · Cited by 49
Zsigmond, E. M., Kobayashi, K., Tzung, K., Li, L., Fuke, Y., & Chan, L. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.16-1921 · Cited by 49
Human Validation of Genes Associated With a Murine Atherosclerotic Phenotype
Pasterkamp, G., van der Laan, S. W., Haitjema, S., Asl, H. F., Siemelink, M. A., Bezemer, T., van Setten, J., Dichgans, M., Malik, R., Worrall, B. B., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306958 · Cited by 49
Adeyo, O., Goulbourne, C. N., Bensadoun, A., Beigneux, A. P., Fong, L. G., & Young, S. G. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12003 · Cited by 48
Afek, A. B., Kogan, E., Maysel-Auslender, S., Mor, A., Regev, E., Rubinstein, A., Keren, G., & George, J. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.01.009 · Cited by 48
Su, Z., Li, Y., James, J. C., MCDUFFIE, M. J., Matsumoto, A. H., Helm, G. A., Weber, J. L., Lusis, A. J., & Shi, W. (2005) · Genetics · doi:10.1534/genetics.105.051912 · Cited by 48
Bouchareychas, L., & Raffaï, R. L. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5020030 · Cited by 55
Noguchi, T., Ebina, K., Hirao, M., Otsuru, S., Guess, A. J., Kawase, R., Ohama, T., Yamashita, S., Etani, Y., Okamura, G., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.055 · Cited by 48
Agrawal, H., Choy, H.-H., Liu, J., Auyoung, M., & Albert, M. A. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.313608 · Cited by 48
The role of circulating precursors in vascular repair and lesion formation
Sata, M., Fukuda, D., Tanaka, K., Kaneda, Y., Yashiro, H., & Shirakawa, I. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00488.x · Cited by 48
Ishii, T. M., Zerr, P., Xia, X., Bond, C. T., Maylie, J., & Adelman, J. P. (1998) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(98)93007-5 · Cited by 47
Cellular and Molecular Mechanisms of Atherosclerosis with Mouse Models
Ohashi, R., Mu, H., Yao, Q., & Chen, C. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.04.002 · Cited by 49
The biology of the artery wall in atherogenesis
O’Brien, K. D., & Chait, A. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30176-6 · Cited by 48
Huang, H., Lin, Y., Panyod, S., Chen, R.-A., Lin, Y., Chai, L. M. X., Hsu, C., Wu, W., Lu, K., Huang, Y., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115872 · Cited by 48
Wang, Y. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.018 · Cited by 47
Atherogenesis and metabolic dysregulation in LDL receptor–knockout rats
Sithu, S. D., Malovichko, M. V., Riggs, K. A., Wickramasinghe, N. S. M. D., Winner, M. G., Agarwal, A., Hamed-Berair, R. E., Kalani, A., Riggs, D. W., Bhatnagar, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.86442 · Cited by 50
Li, S., Cao, H., Shen, D., Chen, C., Xing, S., Dou, F., & Jia, Q. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-2942-9 · Cited by 48
Matsushima, Y., Sakurai, T., Ohoka, A., Ohnuki, T., Tada, N., Asoh, Y., & Tachibana, M. (2001) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.8.71 · Cited by 47
Botti, T. P., Amin, H., Hiltscher, L., & Wissler, R. W. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05825-x · Cited by 47
Fu, T., Kashireddy, P. V., & Borensztajn, J. (2003) · Biochemical Journal · doi:10.1042/bj20030105 · Cited by 47
Kobayashi, T., Miyauchi, T., Iwasa, S., Sakai, S., Fan, J., Nagata, M., Goto, K., & Watanabe, T. (2000) · Pathology International · doi:10.1046/j.1440-1827.2000.01152.x · Cited by 47
Yesilaltay, A., Daniels, K. A., Pal, R., Krieger, M., & Kocher, O. N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008103 · Cited by 47
d’Uscio, L. V. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00469-2 · Cited by 47
Fazio, S., Sanan, D. A., Lee, Y. L., Ji, Z. S., Mahley, R. W., & Rall, S. C. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1873 · Cited by 49
Hyperhomocysteinemia and atherosclerosis.
Yang, F., Tan, H., & Wang, H. (2005) · PubMed · Cited by 47
Jiang, F., Gibson, A. P., & Dusting, G. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01140-2 · Cited by 47
Modulation of the lipid binding properties of the N‐terminal domain of human apolipoprotein E3
Weers, P. M. M., Narayanaswami, V., & Ryan, R. O. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02282.x · Cited by 47
Increased response to cholesterol feeding in apolipoprotein C1-deficient mice
van Ree, J. H., Hofker, M. H., van den Broek, W. J. A. A., van Deursen, J. M. A., van der Boom, H., Frants, R. R., Wieringa, B., & Havekes, L. M. (1995) · Biochemical Journal · doi:10.1042/bj3050905 · Cited by 47
Fu, T., Kozarsky, K., & Borensztajn, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310892200 · Cited by 47
Research methods for animal models of atherosclerosis (Review)
Zhang, Y., Fatima, M., Hou, S., Bai, L., Zhao, S., & Liu, E. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12511 · Cited by 56
Lin, J. B., Phillips, E. H., Riggins, T. E., Sangha, G. S., Chakraborty, S., Lee, J. C. L., Lycke, R., Hernandez, C., Soepriatna, A. H., Thorne, B. R. H., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511131 · Cited by 46
Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE−/− mice
Zhao, Y., Kuge, Y., Zhao, S., Morita, K., Inubushi, M., Strausś, H. W., Blankenberg, F. G., & Tamaki, N. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0433-2 · Cited by 49
Metadata
- Authors
- Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Lawrence Berkeley National Laboratory (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1992-10
- Volume
- 71
- Issue
- 2
- Pages
- 343-353
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2048890665
- Cited by
- 2,263
- References
- 45
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 28 · 2023: 32 · 2022: 52 · 2021: 39 · 2020: 60 · 2019: 69 · 2018: 57 · 2017: 66 · 2016: 57 · 2015: 71 · 2014: 71 · 2013: 82 · 2012: 75
- FWCI
- 72.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17)
- National Heart, Lung, and Blood Institute (HL 33714, R01HL032435, HL32435)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- apolipoprotein E deficiency, hypercholesterolemia, atherosclerosis, ApoE-deficient mice, homologous recombination, embryonic stem cells, serum cholesterol, VLDL, intermediate density lipoprotein, high-fat diet, aortic atherosclerotic lesions, coronary arteries, pulmonary artery, animal models of atherosclerosis
- MeSH terms
- Animals, Aorta, Apolipoproteins E, Arteriosclerosis, Cholesterol, Coronary Vessels, Disease Models, Animal, Hypercholesterolemia, Lipoproteins, Lipoproteins, VLDL, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Pulmonary Artery, Stem Cells, Mice, Lipoproteins, IDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review